Bachelor of Science in Pharmacy (BScPharm) - University of Alberta, 1988
Hospital Pharmacy General Clinical Residency - Royal Columbian Hospital, New Westminster BC, 1989
Doctor of Pharmacy (PharmD) - State University of New York at Buffalo, New York, 1992
Clinical Register, Alberta College of Pharmacists
Additional Prescribing Authorization (APA) since 2007
North American Menopause Society (NAMS) Certified Menopause Practitioner (NCMP)
Awards and Honours (Selected)
Canadian Pharmacist of the Year (Canadian Pharmacists Association), 2016
Faculty of Merit Award for 2012, University of Alberta, 2013
CSHP Alberta Branch Enhancing Pharmacy Practice Recognition Program, 2011
Rutherford Award for Excellence in Undergraduate Teaching, University of Alberta, 2011
Canadian Pharmacists Association (CPhA) Patient Care Achievement Award for Specialty Practice, 2011
APEX Award of Excellence Award (Alberta College of Pharmacists and Alberta Pharmacists Association), 2011
Alberta Pharmacy Centennial Award of Distinction, 2011
Bristol Myers Squibb Teaching Excellence Award, 2010
CSHP AB Branch, Enhancing Patient Care through Prescribing Recognition Award, 2009
Honourable Mention, Bristol Myers Squibb Teaching Excellence Award, 2009
Fellow, Canadian Society of Hospital Pharmacists (CSHP), 2008
Canadian College of Clinical Pharmacists (CCCP) Merck Frosst Meritorious Service Award, 2005
Practitioner Award 1998, CSHP Alberta Branch, 1998
Menopause Clinic, Lois Hole Hospital for Women at RAH site
Multidisciplinary Bone Health Clinic, Kaye Clinic
Professional Service/Committees (Selected)
Osteoporosis Canada (OC) Scientific Advisory Committee (SAC), Executive Committee and SAC consultant
Board of Directors, SIGMA Canadian Menopause Society
My goals of my research program are summarized as follows:
1. To study aspects of women’s health to enhance our understanding of specific issues in women’s health and improve the quality of care of women.
2. To evaluate interventions to identify patients at high risk for osteoporotic fractures and to enhance the care of patients with osteoporosis.
3. To develop innovative techniques to influence pharmacists’ practice specifically in the areas of women’s health and osteoporosis.
Selected Publications (*corresponding author)
Sydora BC, Yuksel N, Veltri NL, Marillier J, Sydora CP, Yaskina M, Battochio L, Shandro TML, Ross S*. Patient characteristics, menopausal symptoms, and care provided at an interdisciplinary menopause: retrospective chart review. Menopause 2017 Jul 10 [Epub ahead of print]
Kwon S, Wang A, Sadowski C, Yuksel N, Doschak MR*. Urinary bone turnover markers as target indicators for monitoring bisphosphonate drug treatment in the management of osteoporosis. Curr Drug Targets 2017 July 4 [Epub ahead of print].
Yuksel N*, Brochu L, Malik B, Ogbogu U. Promotion and marketing of bioidentical hormone therapy on the internet: A content analysis of websites. Menopause 2017;June 12 [Epub ahead of print].
Siyam T, Ross S, Campbell S, Eurich DT, Yuksel N*. The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oopherectomy: a systematic review. BMC Women’s Health 2017;17(1):22. doi: 10.1186/s12905-017-0370-6.
Guirguis L*, Hughes C, Makowsky M, Sadowski C, Schindel T, Yuksel N. Survey of pharmacist prescribing in Alberta. Am J Health-Syst Pharm 2017;74(2):62-69
Sydora B, Fast H, Campbell S, Yuksel N, Lewis JE, Ross SJ*. Use of the Menopause-Specific Quality of Life (MENQOL) questionnaire in research and clinical practice: a comprehensive scoping review. Menopause 2016;23(9):1038-51.
Schindel TJ, Yuksel N, Breault R, Daniels J, Varnhagen S, Hughes CA*. Perceptions of Pharmacists' Roles in an Era of Expanding Scopes of Practice. Res Social Adm Pharm 2017;13(1): 148-161.
Sadoswki CA, Lyder C, Yuksel N* Beliefs and current practices of pharmacists with bisphosphonate use for osteoporosis in patients with renal insufficiency. Can J Hosp Pharm 2016;69(1):14-22.
Croden J, Ross S, Yuksel N, Sydora BC*. A survey of the availability in Canadian pharmacy chains of over-the-counter natural health products for menopause symptoms. BMC Complement Altern Medicine 2015;15(1): 86. doi: 10.1186/s1290601506085.
Shifren JL*, Gass MLS for the NAMS Recommendations for Clinical Care of Midlife Women Working Group (note: part of working group). The North American Menopause Society Recommendations for Clinical Care of Midlife Women. Menopause 2014;21(10):1-25.
Wang E, Marnoch C, Khurana R, Sia W, Yuksel N*. Hemorrhagic complications of peripartum anticoagulation: A Retrospective Chart Review. Obstet Med 2014;7(2):77-83
Guirguis LM, Makowsky M*, Hughes C, Sadowski C, Yuksel N. How have pharmacists in different practice settings integrated prescribing privileges into practice in Alberta? A Qualitative Exploration. J Clin Pharm Ther 2014 Aug;39(4):390-8.
Hughes C, Makowsky M, Sadowski C, Schindel T, Yuksel N, Guirguis LM*. What prescribing means to pharmacists: A qualitative exploration of practicing pharmacists in Alberta. Int J Pharm Pract. 2014;22:283-291.
Makowsky M, Guirguis LM*, Hughes C, Sadowski C, and Yuksel N. Factors influencing pharmacists’ adoption of prescribing: qualitative application of the diffusion of innovations theory. Implement Science 2013; 8:109: 1 – 11.
Siyam T, Yuksel N*. Beliefs about Bioidentical Hormone Therapy: A cross-sectional survey of pharmacists. Maturitas 2013;74(2):196-202.
Schindel TJ*, Kehrer JP, Yuksel N, Hughes CA. University-based continuing education for pharmacists: Doing what universities do best. Am J Pharm Educ 2012; 76(2): Article 20.
Yuksel N* Practice spotlight: Pharmacist practice in an outpatient menopause clinic. Can J Hosp Pharm 2012;65(1):43–44.
Yuksel N*, Tsuyuki RT, Majumdar SR. Predictors of bone mineral density testing in patients at high risk of osteoporosis: secondary analyses from the OSTEOPHARM randomized trial. J Clin Densitometry. 2012:15(1):61-6.
Guirguis L*, Cooney D, Dolovich L, Eberhart F, Hughes C, Makowsky M, Sadowski C, Schindel T, Yuksel N. Exploring pharmacists’ understanding and adoption of prescribing in two Canadian jurisdictions: design and rationale for a mixed methods approach. Can Pharm J 2011;144(5):240-244.
Yuksel N*. Pharmacy course in Women’s and Men’s Health. Am J Pharm Educ 2011; Aug 10;75(6):119
Chubaty A,, Schuurmans N, Shandro MT, Yuksel N*. Practice Patterns With Hormone Therapy After Surgical Menopause. Maturitas 2011;69:69-73.
Yuksel N*, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist initiated screening program for osteoporosis: Randomized controlled trial. Osteoporosis Int 2010;21:391-398.
“Not having heard something is not as good as having heard it;
having heard it is not as good as having seen it;
having seen it is not as good as knowing it;
knowing it is not as good as putting it into practice.”
Xunzi, chinese proverb
At the heart of my teaching philosophy is creating an effective learning environment in the classroom and in the clinical setting. The learning environment is critical in making students feel comfortable with applying knowledge and participating in the learning process. I strive to create an environment that is conducive to learning and motivating to students. I believe the environment is set by displaying passion in what you teach, being committed to the students’ progress and showing that you care about their learning.
My main areas of teaching is in the areas of Women's Health (ie hormonal contraception, menopause, menstrual related disorders, Endometriosis, PCOS, etc), Osteoporosis as well as Gastrointestinal Diseases (ie IBS, IBD etc). I teach and coordinate a course on Women's and Men's Health which is offered in the winter term of 3rd year and a course on Gastrointestinal Diseases which is offered in the fall term of 2nd year.
Students will develop fundamental knowledge in the areas of reproductive and sexual health, as well as musculoskeletal/joint conditions and will apply therapeutic and pharmaceutical science knowledge to various patient care scenarios, with increasing complexity. Students will further develop their critical thinking and self-directed learning skills, along with their breadth and depth of therapeutic knowledge, as they incorporate principles of evidence-based therapeutic decision making within the patient care process framework. (Restricted to Pharmacy students.)Fall Term 2020